Kohei Miyazono

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Venues

Cancer science

Molecular oncology

Science signaling

Nature communications

University of Tokyo

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Tokyo Aug 01 2000

Japan

Professor :: Molecular Pathology

Publications

Shiori Tokizaki, Katarzyna A Podyma-Inoue, Takehisa Matsumoto, Kazuki Takahashi, Miho Kobayashi, Haruka Ibi, Shizuka Uchida, Sadahiro Iwabuchi, Hiroyuki Harada, Shinichi Hashimoto, Kohei Miyazono, Mikako Shirouzu, Tetsuro Watabe
Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks. Cancer science (2023)
Yutaro Tsubakihara, Yae Ohata, Yukari Okita, Shady Younis, Jens Eriksson, Mikael Erik Sellin, Jiang Ren, Peter Ten Dijke, Kohei Miyazono, Atsuhiko Hikita, Takeshi Imamura, Mitsuyasu Kato, Carl-Henrik Heldin, Aristidis Moustakas
TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition. Molecular oncology 16 (12) (2022)
Kei Takahashi, Ko Abe, Shimpei I Kubota, Noriaki Fukatsu, Yasuyuki Morishita, Yasuhiro Yoshimatsu, Satoshi Hirakawa, Yoshiaki Kubota, Tetsuro Watabe, Shogo Ehata, Hiroki R Ueda, Teppei Shimamura, Kohei Miyazono
An analysis modality for vascular structures combining tissue-clearing technology and topological data analysis. Nature communications 13 (1) (2022)
Sau Yee Kok, Hiroko Oshima, Kei Takahashi, Mizuho Nakayama, Kazuhiro Murakami, Hiroki R Ueda, Kohei Miyazono, Masanobu Oshima
Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation. Nature communications 12 (1) (2021)
Yusaku Momoi, Jun Nishida, Kosuke Miyakuni, Masafumi Kuroda, Shimpei I Kubota, Kohei Miyazono, Shogo Ehata
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness. Cancer science 112 (8) (2021)
Kosuke Miyakuni, Jun Nishida, Daizo Koinuma, Genta Nagae, Hiroyuki Aburatani, Kohei Miyazono, Shogo Ehata
Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer. Molecular oncology (2021)
Kei Takahashi, Ryo Tanabe, Shogo Ehata, Shimpei I Kubota, Yasuyuki Morishita, Hiroki R Ueda, Kohei Miyazono
Visualization of the cancer cell cycle by tissue-clearing technology using the Fucci reporter system. Cancer science 112 (9) (2021)
Ryo Tanabe, Kohei Miyazono, Tomoki Todo, Nobuhito Saito, Caname Iwata, Akiyoshi Komuro, Satoshi Sakai, Erna Raja, Daizo Koinuma, Masato Morikawa, Bengt Westermark, Carl-Henrik Heldin
PRRX1 induced by BMP signaling decreases tumorigenesis by epigenetically regulating glioma-initiating cell properties via DNA methyltransferase 3A. Molecular oncology (2021)
Tomohiko Fukuda, Risa Fukuda, Kohei Miyazono, Carl-Henrik Heldin
Tumor Promoting Effect of BMP Signaling in Endometrial Cancer. International journal of molecular sciences 22 (15) (2021)
Shimpei I Kubota, Kei Takahashi, Tomoyuki Mano, Katsuhiko Matsumoto, Takahiro Katsumata, Shoi Shi, Kazuki Tainaka, Hiroki R Ueda, Shogo Ehata, Kohei Miyazono
Whole-organ analysis of TGF-β-mediated remodelling of the tumour microenvironment by tissue clearing. Communications biology 4 (1) (2021)
Yusuke Tamura, Shuichi Tsutsumi, Kohei Miyazono, Daizo Koinuma
PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer. Cancer science 113 (3) (2021)
Kei Takahashi, Shogo Ehata, Kensuke Miyauchi, Yasuyuki Morishita, Keiji Miyazawa, Kohei Miyazono
Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Molecular oncology 15 (1) (2020)
Jun Nishida, Yusaku Momoi, Kosuke Miyakuni, Yusuke Tamura, Kei Takahashi, Daizo Koinuma, Kohei Miyazono, Shogo Ehata
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis. Nature cell biology 22 (4) (2020)
Masato Morikawa, Yoshihide Mitani, Katarina Holmborn, Taichi Kato, Daizo Koinuma, Junko Maruyama, Eleftheria Vasilaki, Hirofumi Sawada, Mai Kobayashi, Takayuki Ozawa, Yasuyuki Morishita, Yasumasa Bessho, Shingo Maeda, Johan Ledin, Hiroyuki Aburatani, Ryoichiro Kageyama, Kazuo Maruyama, Carl-Henrik Heldin, Kohei Miyazono
The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension. Science signaling 12 (607) (2019)
Yoko Katsuno, Dominique Stephan Meyer, Ziyang Zhang, Kevan M Shokat, Rosemary J Akhurst, Kohei Miyazono, Rik Derynck
Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. Science signaling 12 (570) (2019)
Satoshi Hokari, Yusuke Tamura, Atsushi Kaneda, Akihiro Katsura, Masato Morikawa, Fumihiko Murai, Shogo Ehata, Shuichi Tsutsumi, Yuichi Ishikawa, Hiroyuki Aburatani, Toshiaki Kikuchi, Kohei Miyazono, Daizo Koinuma
Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer. Molecular oncology 14 (2) (2019)
Erna Raja, Masato Morikawa, Jun Nishida, Ryo Tanabe, Kei Takahashi, Howard J Seeherman, Nobuhito Saito, Tomoki Todo, Kohei Miyazono
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis. Cancer science 110 (11) (2019)

Kohei Miyazono.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kohei Miyazono